4.2 Article

LAK cell therapy of AML: Not to be lost in translation

Journal

EXPERIMENTAL HEMATOLOGY
Volume 39, Issue 11, Pages 1045-1046

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.exphem.2011.08.005

Keywords

-

Ask authors/readers for more resources

Expanding highly cytotoxic lymphokine activated natural killer cells and cytokine induced killer T cells by Good Manufacturing Practice-quality cultures is an important step toward effective use of those killer cells to treat acute myeloid leukemia patients receiving stem cell transplantation. Elucidating how those killer cells recognize leukemia stem cells will be the next challenge. (C) 2011 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available